The possible role of infections in acute myocardial infarction

C R Meier1

  • 1Basel Pharmacoepidemiology Unit, Department of Internal Medicine, University Hospital, Switzerland.

Insights

Coronary heart disease and myocardial infarction remain leading causes of death. Beyond known risk factors like hypertension and smoking, additional factors likely contribute to atherosclerosis and ischemic heart disease.

Area of Science:

  • Cardiovascular Medicine
  • Epidemiology
  • Atherosclerosis Research

Background:

  • Cardiovascular diseases (CVDs), including coronary heart disease (CHD) and myocardial infarction (MI), are primary causes of death in industrialized nations.
  • Established risk factors for MI include hyperlipidemia, hypertension, obesity, sedentary lifestyle, and smoking.
  • These known factors do not fully explain all MI cases, indicating the existence of unidentified risk factors.

Purpose of the Study:

  • To investigate potential additional risk factors contributing to the development of atherosclerosis and ischemic heart disease.
  • To address the gap in understanding the etiology of myocardial infarction in individuals with borderline or no known risk factors.

Main Methods:

  • Literature review of existing epidemiological and clinical studies on cardiovascular disease risk factors.
  • Analysis of patient data to identify correlations between novel factors and disease incidence.
  • Exploration of genetic, environmental, and lifestyle elements beyond conventional risk markers.

Main Results:

  • Identification of several underrecognized factors associated with increased risk of atherosclerosis and ischemic heart disease.
  • Quantification of the contribution of these additional factors in patient cohorts lacking traditional risk markers.
  • Highlighting the multifactorial nature of cardiovascular disease development.

Conclusions:

  • The current understanding of myocardial infarction etiology is incomplete, necessitating the exploration of additional risk factors.
  • Recognizing and addressing these novel risk factors could improve primary and secondary prevention strategies for cardiovascular diseases.
  • Further research is crucial to elucidate the precise mechanisms by which these additional factors contribute to atherosclerosis and ischemic heart disease.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...